Chronic Lymphocytic Leukemia (CLL) Panel


Test Name

Chronic Lymphocytic Leukemia (CLL) Panel

Test Code

F CLL

Synonyms

MYB (6q23), ATM (11q22.3), +12, DLEU1 (13q14.2), TP53 (17p13)

Associations

Chronic Lymphocytic Leukemia(CLL)

The Vysis CLL Fish probe kit is indicated for detecting deletion of the LSI TP53 probe target (17p-) as an aid in identifying those patients with CLL for whom treatment with VENCLEXTA® (venetoclax) is indi

CPT Codes

88374 x4

Turnaround Time

5

Specimen Requirements

5mL peripheral blood in sodium heparin 3mL bone marrow in sodium heparin Fixed cytogenetically prepared cells in sterile centrifuge tube with pellet visible in 3:1, Methanol:Acetic Acid

Specimen Stability

Blood and bone marrow = 4°C to 25°C, specimens are stable up to 72 hours Fixed cell pellets are stable for years when stored at -28°C to -15°C

Storage & Handling

4°C to 25°C during transit, but specimens may be transported on refrigerated gel packs. Do not allow the gel pack to come in contact with the specimen. Do not freeze. Extreme temperatures should be avoided.

Causes for Rejections

Clotted specimen; Specimens exposed to extreme temperature; Anticoagulant toxic to cells; Insufficient number of cells

Description

Leukemias are a diverse group of diseases often characterized by multiple genetic aberrations distributed across the genome. In some cases, the same genetic aberrations are shared by different types of leukemia. Fluorescence in situ hybridization (FISH) h

References

  1. Emili Montserrat. (2002). Classical and new prognostic factors in chronic lymphocytic leukemia: where to now? The Hematology Journal. 3:7.
  2. Stilgenbauer S et al. (2002). Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course. Leukemia. 16(6):993-1007.
  3. Pettitt A.R. et al. (2001). Dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation. Blood. 98(3):814-822.
  4. Dohner et al. (2000). Chromosomal Abnormalities in Chronic Lymphocytic Leukemia. NEJM. 343:1910.

    Etiam magna arcu, ullamcorper ut pulvinar et, ornare sit amet ligula. Aliquam vitae bibendum lorem. Cras id dui lectus. Pellentesque nec felis tristique urna lacinia sollicitudin ac ac ex. Maecenas mattis faucibus condimentum. Curabitur imperdiet felis at est posuere bibendum. Sed quis nulla tellus.

    ADDRESS

    63739 street lorem ipsum City, Country

    PHONE

    +12 (0) 345 678 9

    EMAIL

    info@company.com